Zydus announces positive topline results from completed EVIDENCES-X Phase II(b) trial

For evaluation of efficacy and safety of Saroglitazar Magnesium in patients with MASH
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.